SciDev Trading Update
| Stock | Scidev Ltd (SDV.ASX) |
|---|---|
| Release Time | 20 Apr 2026, 9:07 a.m. |
| Price Sensitive | Yes |
SciDev Provides 3Q FY26 Trading Update
- Achieved third consecutive quarter of positive Underlying EBITDA
- Revised FY26 revenue guidance to $82-$87 million due to headwinds in Energy Services and Rum Jungle project delays
- Expects FY26 Underlying EBITDA of approximately $4 million
SciDev Ltd (ASX:SDV) provided its 3Q FY26 trading update, reporting its third consecutive quarter of positive Underlying EBITDA, reaching $1.1 million in 3Q FY26 and $2.2 million YTD, with EBITDA margin improving to 6% in the quarter. The company's Process Chemistry business continued to perform well and remains on track for record full-year revenues in FY26. However, the company experienced two specific headwinds that require a revision to FY26 revenue guidance. Continued cost-reduction pressure from upstream E&P companies has intensified competition in commoditised friction reduction chemical sales and tempered adoption of higher-value specialty chemical products, reducing volumes in the near term. Additionally, adverse weather events in the Northern Territory and global shipping disruptions have shifted a meaningful portion of Rum Jungle project revenues from FY26 into FY27. As a result, FY26 revenue guidance has been revised to $82 to $87 million (previous guidance $100 to $110 million), while FY26 underlying EBITDA is expected to be approximately $4 million. The company noted that each revision has been driven by distinct, identifiable factors, and the headwinds in the Energy Services business are largely cyclical or timing in nature, with revenues deferred into FY27 rather than lost.
FY26 revenue guidance revised to $82 to $87 million (previous guidance $100 to $110 million). FY26 underlying EBITDA expected to be approximately $4 million.
The company enters FY27 with a meaningfully improved cost structure and a set of identifiable revenue recovery drivers, with the Board and management team confident in a material improvement in earnings in FY27 relative to FY26. Key drivers include continued expansion of target sales opportunities in the Permian and Haynesville Basins, onboarding of new CatChek customers, successful delivery of the Rum Jungle project, and ongoing delivery of field trials and conversion into long-term supply arrangements in the Process Chemistry business.